A killer cocktail {#cesec10}
=================

A cocktail of bacteria-killing viruses can prevent cholera infection in animal models. That\'s according to US scientists who infected baby mice and baby rabbits with an oral dose of three bacteriophages that retain their ability to kill *Vibrio cholerae* in the small intestine, the site of infection in people. The animals received the cocktail 3--24 h before infection, none had cholera symptoms. The bacteriophages destroy virulence factors on the surface of the bacteria. It\'s a checkmate of a treatment strategy: for the bacteria to evolve resistance they need mutations in these surface proteins---a change that will likely make them less infectious.

Dengue roulette {#cesec20}
===============

A first infection with dengue virus usually causes only mild symptoms. When the virus infects again, though, it causes a vicious and potentially deadly infection in some people, especially in the roughly 15% of patients who have full-blown haemorrhagic fever and shock. Findings from a new study suggest these differing reactions aren\'t down to luck but an individuals\' antibody signature. The researchers analysed blood samples from patients in Thailand and found that the antibodies in those with severe infection were a variant that elicits a response that kills blood-clotting platelets. This finding can help identify and better treat individuals at high risk of severe disease.

Southern resistance {#cesec30}
===================

The use of insecticide-treated bednets and indoor residual spraying has bred [insect resistance](http://dx.org/10.1371/journal.pgen.1006539){#interrefs10} among malaria-transmitting mosquitoes in Africa, say researchers at the Liverpool School of Tropical Medicine, UK. Findings from their continent-wide genetic analysis of *Anopheles funestus* show that genes that confer resistance to the commonly used pyrethroid insecticides have swept through southern African since 2002, when control efforts were stepped up. A better understanding of the potential spread of these resistance genes is needed to help control programmes to manage resistance and retain the effectiveness of these important insecticides.

One-shot Zika vaccine {#cesec40}
=====================

A new candidate vaccine against [Zika virus](http://dx.doi.org/10.1038/nature21428){#interrefs20} could provide protection with a single dose. Preclinical tests of the vaccine, which delivers viral mRNAs, showed promising immune responses in both mice and monkeys. mRNAs are usually detected by host immune cells and cleared from the body within minutes, but those in the vaccine have been modified to slip under this immunological radar and enter cells more easily. Once inside the cells, they are taken up by cellular protein-making machinery and induce the production of the viral protein they encode. The US researchers hope to start clinical trials within 12--18 months.

Repurposing for chikungunya {#cesec50}
===========================

Arthritis in the joints, caused by T cells inappropriately trafficked there, is a hallmark of acute chikungunya infection, starting 3 weeks after infection and lasting up to 3--4 years. Two teams of researchers have come up with a potential way to treat patients: use existing drugs approved for autoimmune diseases. One group, from Europe and Singapore, used the multiple sclerosis drug [fingolimod](http://dx.doi.org/10.1126/scitranslmed.aal1333){#interrefs30} (which prevents T cells from leaving the lymph nodes) to reduce joint inflammation in mice. Another group, from the USA, used the rheumatoid arthritis drug abatacept, which hinders T-cell activation by lymph nodes. [Abatacept](http://dx.doi.org/10.1126/scitranslmed.aah3438){#interrefs40} also reduced joint inflammation in mice and when given with a chikungunya-targeted antibody it eliminated the live virus. The researchers were concerned that the use of these immunity-suppressing drugs could allow the virus to escape immune control. Thankfully, viral loads in the mice in these experiments did not increase, allowing further investigation into potential application in human beings. The combination of abatacept and an antiviral, though clearing live virus, left viral genetic material which itself can trigger an immune response in the chronic phase, suggesting that other treatment strategies might be needed to treat chronic chikungunya.
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Vampire piggy-backing {#cesec60}
=====================

Invasive feral pigs and wild boar, which are spreading across Brazil, cause damage to crops and native fauna, but that\'s not the half of it. The animals are a source of blood for vampire bats, which spread rabies, hantaviruses, and coronaviruses, raising concerns about new potential pandemics of these viruses in Brazil. Wild pigs first entered the country from Uruguay. Since 2007, the population has exploded, increasing by 500% due to changes in rural farming practices that have shifted to cultivation of wild meat. Other pigs entered the country in colonial times with Portuguese settlers. The alarming rise in these animals was documented by Brazilian researchers who scoured 12 years of data from infrared camera traps in the Brazilian Pantanal and Atlantic forest regions in the south of the country.

For more on **preventing cholera with bacteriophages** see *Nat Commun* 2017; **8:** 14187For more on **determining dengue severity** see *Science* 2017; **355:** 395--98For more on **wild pigs in Brazil** see *Front Ecol Environ* 2016; **14:** 505--06
